Inflammation at the molecular interface of atherogenesis: An Anthropological Journey

American Journal of Pathology

Volumn 173, Issue 5, 2008, Pages 1253-1264

  Lamon, Brian D ^a,b   Hajjar, David P ^a  

^a Weill Cornell Medical College of Cornell University   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; CARBOHYDRATE; CYTOKINE; FATTY ACID; GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1BETA; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL INFILTRATION; CELL PROLIFERATION; DIABETES MELLITUS; DIET; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENVIRONMENTAL EXPOSURE; GENOMICS; HUMAN; HYPERTENSION; INFLAMMATION; LIFESPAN; MACROPHAGE; MEDIATOR; NONHUMAN; NUTRITION; OXIDATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SANITATION; SMOKING; SMOOTH MUSCLE FIBER; SOCIOECONOMICS; THROMBOCYTE; THROMBOSIS;

EID: 55349145657     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2008.080442     Document Type: Review

References (107)

1. American Heart Association: Heart Disease and Stroke Statistics-2008 Update. Dallas, American Heart Association, 2008, pp. 2-6
2. Packard RR, Libby P: Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008, 54:24-38
3. Mayerl C, Lukasser M, Sedivy R, Niederegger H, Seiler R, Wick G: Atherosclerosis research from past to present - on the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow. Virchows Arch 2006, 449:96-103
4. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809
5. Epstein SE, Zhou YF, Zhu J: Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999, 100:e20-e28
6. Marcus AJ, Broekman MJ, Drosopoulos JH, Olson KE, Islam N, Pinsky DJ, Levi R: Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Semin Thromb Hemost 2005, 31:234-246
7. Davignon J, Ganz P: Role of endothelial dysfunction in atherosclerosis. Circulation 2004, 109(Suppl 1):III27-III32
8. Hajjar DP, Gotto AM: Targeting CD36: modulating inflammation and atherogenesis. Curr Atheroscler Rep 2003, 5:155-156
9. Moore KJ, Freeman MW: Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 2006, 26:1702-1711
10. Boudjeltia KZ, Legssyer I, Van Antwerpen P, Kisoka RL, Babar S, Moguilevsky N, Delree P, Ducobu J, Remacle C, Vanhaeverbeek M, Brohee D: Triggering of inflammatory response by myeloperoxidase-oxidized LDL. Biochem Cell Biol 2006, 84:805-812
11. Martín-Fuentes P, Civeira F, Recalde D, Garcia-Otin AL, Jarauta E, Marzo I, Cenarro A: Individual variation of scavenger receptor expression in human macrophages with oxidized low-density lipoprotein is associated with a differential inflammatory response. J Immunol 2007, 179:3242-3248
12. Collins RG, Velji R, Guevara NV, Hicks MJ, Chan L, Beaudet AL: P-selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 2000, 191:189-194
13. Tikellis C, Jandeleit-Dahm KA, Sheehy K, Murphy A, Chin-Dusting J, Kling D, Sebokova E, Cooper ME, Mizrahi J, Woollard KJ: Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules. Atherosclerosis 2008, 199:55-64
14. Ayada K, Yokota K, Kobayashi K, Shoenfeld Y, Matsuura E, Oguma K: Chronic infections and atherosclerosis. Ann NY Acad Sci 2007, 1108:594-602
15. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV: Pathogenesis of chronic Chagas heart disease. Circulation 2007, 115:1109-1123
16. Mussa FF, Chai H, Wang X, Yao Q, Lumsden AB, Chen C: Chlamydia pneumoniae and vascular disease: an update. J Vasc Surg 2006, 43:1301-1307
17. Nicholson AC, Hajjar DP: Herpesvirus in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders? Arterioscler Thromb Vasc Biol 1998, 18:339-348
18. Seymour GJ, Ford PJ, Cullinan MP, Leishman S, Yamazaki K: Relationship between periodontal infections and systemic disease. Clin Microbiol Infect 2007, 13(Suppl 4):3-10
19. Mahmoudi M, Curzen N, Gallagher PJ: Atherogenesis: the role of inflammation and infection. Histopathology 2007, 50:535-546
20. Stassen FR, Vainas T, Bruggeman CA: Infection and atherosclerosis. An alternative view on an outdated hypothesis. Pharmacol Rep 2008, 60:85-92
21. Hirsch EZ, Chisolm III GM, White HM: Reendothelialization and maintenance of endothelial integrity in longitudinal denuded tracks in the thoracic aorta of rats. Atherosclerosis 1983, 46:287-307
22. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T: Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434-438
23. Wu Y, Ip JE, Huang J, Zhang L, Matsushita K, Liew CC, Pratt RE, Dzau VJ: Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res 2006, 99:315-322
24. Zampetaki A, Kirton JP, Xu Q: Vascular repair by endothelial progenitor cells. Cardiovasc Res 2008, 78:413-421
25. Dome B, Dobos J, Tovari J, Paku S, Kovacs G, Ostoros G, Timar J: Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease. Cytometry A 2008, 73:186-193
26. Tabata T, Mine S, Kawahara C, Okada Y, Tanaka Y: Monocyte chemoattractant protein-1 induces scavenger receptor expression and monocyte differentiation into foam cells. Biochem Biophys Res Commun 2003, 305:380-385
27. Popa C, Netea MG, van Riel PL, van der Meer JW, Stalenhoef AF: The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res 2007, 48:751-762
28. Tiwari RL, Singh V, Barthwal MK: Macrophages: an elusive yet emerging therapeutic target of atherosclerosis. Med Res Rev 2008, 28:483-544
29. Bentzon JF, Weile C, Sondergaard CS, Hindkjaer J, Kassem M, Falk E: Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc Biol 2006, 26:2696-2702
30. Doran AC, Meller N, McNamara CA: Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008, 28:812-819
31. Schwartz SM, Virmani R, Rosenfeld ME: The good smooth muscle cells in atherosclerosis. Curr Atheroscler Rep 2000, 2:422-429
32. Langer HF, Gawaz M: Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost 2008, 99:480-486
33. Marcus AJ, Broekman MJ, Safier LB, Ullman HL, Islam N, Sherhan CN, Rutherford LE, Korchak HM, Weissmann G: Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vitro. Biochem Biophys Res Commun 1982, 109:130-137
34. Dokka S, Shi X, Leonard S, Wang L, Castranova V, Rojanasakul Y: Interleukin-10-mediated inhibition of free radical generation in macrophages. Am J Physiol 2001, 280:L1196-L1202
35. Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M: A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002, 196:887-896
36. Cai H: NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res 2005, 96:818-822
37. Salvayre R, Auge N, Benoist H, Negre-Salvayre A: Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 2002, 1585:213-221
38. de Winther MP, Kanters E, Kraal G, Hofker MH: Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 2005, 25:904-914
39. Brand K, Eisele T, Kreusel U, Page M, Page S, Haas M, Gerling A, Kaltschmidt C, Neumann FJ, Mackman N, Baeurele PA, Walli AK, Neumeier D: Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol 1997, 17:1901-1909
40. Kustermans G, El Benna J, Piette J, Legrand-Poels S: Perturbation of actin dynamics induces NF-kappaB activation in myelomonocytic cells through an NADPH oxidase-dependent pathway. Biochem J 2005, 387:531-540
41. Deeb RS, Upmacis RK, Lamon BD, Gross SS, Hajjar DP: Maintaining equilibrium by selective targeting of cyclooxygenase pathways: promising offensives against vascular injury. Hypertension 2008, 51:1-7
42. Cipollone F, Fazia ML, Iezzi A, Cuccurullo C, De Cesare D, Ucchino S, Spigonardo F, Marchetti A, Buttitta F, Paloscia L, Mascellanti M, Cuccurullo F, Mezzetti A: Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. Arterioscler Thromb Vasc Biol 2005, 25:1925-1931
43. Pavlovic S, Du B, Sakamoto K, Khan KM, Natarajan C, Breyer RM, Dannenberg AJ, Falcone DJ: Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages. J Biol Chem 2006, 281:3321-3328
44. Zhang WJ, Bird KE, McMillen TS, LeBoeuf RC, Hagen TM, Frei B: Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice. Circulation 2008, 117:421-428
45. Chen YH, Lin SJ, Chen YL, Liu PL, Chen JW: Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules. Cardiovasc Hematol Disord Drug Targets 2006, 6:279-304
46. Victor VM, Rocha M: Targeting antioxidants to mitochondria: a potential new therapeutic strategy for cardiovascular diseases. Curr Pharm Des 2007, 13:845-863
47. Wohlin M, Helmersson J, Sundstrom J, Arnlov J, Vessby B, Larsson A, Andren B, Lind L, Basu S: Both cyclooxygenase- and cytokine-mediated inflammation are associated with carotid intima-media thickness. Cytokine 2007, 38:130-136
48. Eaton SB: The ancestral human diet: what was it and should it be a paradigm for contemporary nutrition? Proc Nutr Soc 2006, 65:1-6
49. Eaton SB, Eaton III SB: Paleolithic vs. modern diets - selected pathophysiological implications. Eur J Nutr 2000, 39:67-70
50. Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, O'Keefe JH, Brand-Miller J: Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 2005, 81:341-354
51. Simopoulos AP: Evolutionary aspects of diet, essential fatty acids and cardiovascular disease. Eur Heart J Suppl 2001, 3(Suppl D):D8-D21
52. Kris-Etherton PM, Harris WS, Appel LJ: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757
53. Trumbo P, Schlicker S, Yates AA, Poos M: Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc 2002, 102:1621-1630
54. Eaton SB, Eaton III SB, Konner MJ: Paleolithic nutrition revisited: a twelve-year retrospective on its nature and implications. Eur J Clin Nutr 1997, 51:207-216
55. Eaton SB, Eaton III SB, Sinclair AJ, Cordain L, Mann NJ: Dietary intake of long-chain polyunsaturated fatty acids during the paleolithic. World Rev Nutr Diet 1998, 83:12-23
56. Caspari R, Lee SH: Older age becomes common late in human evolution. Proc Natl Acad Sci USA 2004, 101:10895-10900
57. Mustad VA, Etherton TD, Cooper AD, Mastro AM, Pearson TA, Jonnalagadda SS, Kris-Etherton PM: Reducing saturated fat intake is associated with increased levels of LDL receptors on mononuclear cells in healthy men and women. J Lipid Res 1997, 38:459-468
58. Woollett LA, Spady DK, Dietschy JM: Saturated and unsaturated fatty acids independently regulate low density lipoprotein receptor activity and production rate. J Lipid Res 1992, 33:77-88
59. Bradley RL, Fisher FM, Maratos-Flier E: Dietary fatty acids differentially regulate production of TNF-alpha and IL-10 by murine 3T3-L1 adipocytes. Obesity 2008, 16:938-944
60. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J: Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002, 346:1113-1118
61. Wada M, DeLong CJ, Hong YH, Rieke CJ, Song I, Sidhu RS, Yuan C, Warnock M, Schmaier AH, Yokoyama C, Smyth EM, Wilson SJ, FitzGerald GA, Garavito RM, Sui de X, Regan JW, Smith WL: Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem 2007, 282:22254-22266
62. Jacobson TA: Beyond lipids: the role of omega-3 fatty acids from fish oil in the prevention of coronary heart disease. Curr Atheroscler Rep 2007, 9:145-153
63. Shimokawa H, Vanhoutte PM: Dietary cod-liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. Circulation 1988, 78:1421-1430
64. Fox PL, DiCorleto PE: Fish oils inhibit endothelial cell production of platelet-derived growth factor-like protein. Science 1988, 241:453-456
65. Matsumoto M, Sata M, Fukuda D, Tanaka K, Soma M, Hirata Y, Nagai R: Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice. Atherosclerosis 2008, 197:524-533
66. Chow AK, Cena J, Schulz R: Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature. Br J Pharmacol 2007, 152:189-205
67. De Caterina R, Massaro M: Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes. J Membr Biol 2005, 206:103-116
68. Ferrante A, Robinson BS, Singh H, Jersmann HP, Ferrante JV, Huang ZH, Trout NA, Pitt MJ, Rathjen DA, Easton CJ, Poulos A, Prager RH, Lee FS, Hii CS: A novel beta-oxa polyunsaturated fatty acid downregulates the activation of the IkappaB kinase/nuclear factor kappaB pathway, inhibits expression of endothelial cell adhesion molecules, and depresses inflammation. Circ Res 2006, 99:34-41
69. Levitan EB, Cook NR, Stampfer MJ, Ridker PM, Rexrode KM, Buring JE, Manson JE, Liu S: Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein. Metabolism 2008, 57:437-443
70. Kaneto H, Katakami N, Kawamori D, Miyatsuka T, Sakamoto K, Matsuoka TA, Matsuhisa M, Yamasaki Y: Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid Redox Signal 2007, 9:355-366
71. Simopoulos AP: Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins Leukot Essent Fatty Acids 1999, 60:421-429
72. Munteanu A, Zingg JM: Cellular, molecular and clinical aspects of vitamin E on atherosclerosis prevention. Mol Aspects Med 2007, 28:538-590
73. Shirodaria C, Antoniades C, Lee J, Jackson CE, Robson MD, Francis JM, Moat SJ, Ratnatunga C, Pillai R, Refsum H, Neubauer S, Channon KM: Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease. Circulation 2007, 115:2262-2270
74. Aguirre R, May JM: Inflammation in the vascular bed: importance of vitamin C. Pharmacol Ther 2008, 119:96-103
75. Singh U, Devaraj S: Vitamin E: inflammation and atherosclerosis. Vitam Horm 2007, 76:519-549
76. Choi YS, Goto S, Ikeda I, Sugano M: Age-related changes in lipid metabolism in rats: the consequence of moderate food restriction. Biochim Biophys Acta 1988, 963:237-242
77. Fontana L, Meyer TE, Klein S, Holloszy JO: Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci USA 2004, 101:6659-6663
78. Holloszy JO, Fontana L: Caloric restriction in humans. Exp Gerontol 2007, 42:709-712
79. Merry BJ: Molecular mechanisms linking calorie restriction and longevity. Int J Biochem Cell Biol 2002, 34:1340-1354
80. Yang H, Shi M, Story J, Richardson A, Guo Z: Food restriction attenuates age-related increase in the sensitivity of endothelial cells to oxidized lipids. J Gerontol A Biol Sci Med Sci 2004, 59:316-323
81. Stolzenberg-Solomon RZ, Miller III ER, Maguire MG, Selhub J, Appel LJ: Association of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population. Am J Clin Nutr 1999, 69:467-475
82. Chandramohan G, Bai Y, Norris K, Rodriguez-Iturbe B, Vaziri ND: Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys. Am J Nephrol 2008, 28:158-167
83. Ranjit N, Diez-Roux AV, Shea S, Cushman M, Ni H, Seeman T: Socioeconomic position, race/ethnicity, and inflammation in the multi-ethnic study of atherosclerosis. Circulation 2007, 116:2383-2390
84. Tamashiro KL, Hegeman MA, Sakai RR: Chronic social stress in a changing dietary environment. Physiol Behav 2006, 89:536-542
85. Atanackovic D, Schulze J, Kroger H, Brunner-Weinzierl MC, Deter HC: Acute psychological stress induces a prolonged suppression of the production of reactive oxygen species by phagocytes. J Neuroimmunol 2003, 142:159-165
86. Hambrecht R, Gielen S: Essay: hunter-gatherer to sedentary lifestyle. Lancet 2005, 366(Suppl 1):S60-S61
87. Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B, Fletcher GF, Gordon NF, Pate RR, Rodriguez BL, Yancey AK, Wenger NK: Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003, 107:3109-3116
88. Okabe TA, Shimada K, Hattori M, Murayama T, Yokode M, Kita T, Kishimoto C: Swimming reduces the severity of atherosclerosis in apolipoprotein E deficient mice by antioxidant effects. Cardiovasc Res 2007, 74:537-545
89. Laufs U, Werner N, Link A, Endres M, Wassmann S, Jurgens K, Miche E, Bohm M, Nickenig G: Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004, 109:220-226
90. Fadini GP, Agostini C, Sartore S, Avogaro A: Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 2007, 194:46-54
91. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389:610-614
92. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808
93. Edwards KM, Ziegler MG, Mills PJ: The potential anti-inflammatory benefits of improving physical fitness in hypertension. J Hypertens 2007, 25:1533-1542
94. Park YS, Kim J, Misonou Y, Takamiya R, Takahashi M, Freeman MR, Taniguchi N: Acrolein induces cyclooxygenase-2 and prostaglandin production in human umbilical vein endothelial cells: roles of p38 MAP kinase. Arterioscler Thromb Vasc Biol 2007, 27:1319-1325
95. Blann AD, Steele C, McCollum CN: The influence of smoking on soluble adhesion molecules and endothelial cell markers. Thromb Res 1997, 85:433-438
96. Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Horkko S, Barnard J, Reynolds WF, Topol EJ, DiDonato JA, Hazen SL: Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 2007, 13:1176-1184
97. Kangavari S, Matetzky S, Shah PK, Yano J, Chyu KY, Fishbein MC, Cercek B: Smoking increases inflammation and metalloproteinase expression in human carotid atherosclerotic plaques. J Cardiovasc Pharmacol Ther 2004, 9:291-298
98. Zimmerman MR: The paleopathology of the cardiovascular system. Tex Heart Inst J 1993, 20:252-257
99. Cordain L, Eaton SB, Miller JB, Mann N, Hill K: The paradoxical nature of hunter-gatherer diets: meat-based, yet non-atherogenic. Eur J Clin Nutr 2002, 56(Suppl 1):S42-S52
100. Miller DT, Ridker PM, Libby P, Kwiatkowski DJ: Atherosclerosis: the path from genomics to therapeutics. J Am Coll Cardiol 2007, 49:1589-1599
101. Gargalovic PS, Imura M, Zhang B, Gharavi NM, Clark MJ, Pagnon J, Yang WP, He A, Truong A, Patel S, Nelson SF, Horvath S, Berliner JA, Kirchgessner TG, Lusis AJ: Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc Natl Acad Sci USA 2006, 103:12741-12746
102. Lockridge JB, Sailors ML, Durgan DJ, Egbejimi O, Jeong WJ, Bray MS, Stanley WC, Young ME: Bioinformatic profiling of the transcriptional response of adult rat cardiomyocytes to distinct fatty acids. J Lipid Res 2008, 49:1395-1408
103. Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, Sakuma M, Shi C, Zago AC, Garasic J, Damokosh AI, Dowie TL, Poisson L, Lillie J, Libby P, Ridker PM, Simon DI: Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 2006, 113:2278-2284
104. Tuomisto TT, Korkeela A, Rutanen J, Viita H, Brasen JH, Riekkinen MS, Rissanen TT, Karkola K, Kiraly Z, Kolble K, Yla-Herttuala S: Gene expression in macrophage-rich inflammatory cell infiltrates in human atherosclerotic lesions as studied by laser microdissection and DNA array: overexpression of HMG-CoA reductase, colony stimulating factor receptors, CD11A/CD18 integrins, and interleukin receptors. Arterioscler Thromb Vasc Biol 2003, 23:2235-2240
105. Waehre T, Yndestad A, Smith C, Haug T, Tunheim SH, Gullestad L, Froland SS, Semb AG, Aukrust P, Damas JK: Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors. Circulation 2004, 109:1966-1972
106. Montero I, Orbe J, Varo N, Beloqui O, Monreal JI, Rodriguez JA, Diez J, Libby P, Paramo JA: C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 2006, 47:1369-1378
107. Geng YJ, Libby P: Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol 2002, 22:1370-1380